City to sue Merck, Schering-Plough

The city of New Haven, Connecticut will be suing Merck and Schering-Plough on the basis that Vyotrin doesn't work.

New Haven, which has spent $100,000 shy of a half million dollars on Vytorin and Zetia for employees, will seek reimbursement for the tax money it spent on the medications.   

While Merck did not comment, a Schering-Plough spokesperson said the company stood behind its product and would fight any challenge vigorously. 

- check out the Pharmalot blog entry 

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.